1. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy is the most common glomerulonephritis worldwide: a neglected disease in the United States? Kidney Int 84:1998;129–132.
2. Shen P, He L, Li Y, Wang Y, Chan M. Natural history and prognostic factors of IgA nephropathy presented with isolated microscopic hematuria in Chinese patients.
Nephron Clin Pract 106:2007;157–161.
3. Dische FE, Weston MJ, Parsons V. Abnormally thin glomerular basement membranes associated with hematuria, proteinuria or renal failure in adults.
Am J Nephrol 5:1985;103–109.
4. Savige J, Rana K, Tonna S, Buzza M, Dagher H, Wang YY. Thin basement membrane nephropathy.
Kidney Int 64:2003;1169–1178.
5. Wang C, Liu X, Peng H, Tang Y, Tang H, Chen Z, Lou T, Zhang H. Mesangial cells stimulated by immunoglobulin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation.
ArchMed Res 41:2010;255–260.
6. Tiebosch AT, Frederik PM, van Breda Vriesman PJ, Mooy JM, van Rie H, van de Wiel TW, Wolters J, Zeppenfeldt E. Thin-basement-membrane nephropathy in adults with persistent hematuria.
N Engl J Med 320:1989;14–18.
7. Abbas AK, Lichtman AH, Pober JS. Cytokines. In: Abbas AK, Lichtman AH, Pober JS, Cellular and Molecular Immunology. 1997. WB Saunders; Philadelphia: p. 249–277.
8. Syrjänen J, Hurme M, Lehtimäki T, Mustonen J, Pasterneck A. Polymorphism of the cytokine genes and IgA nephropathy.
Kidney Int 61:2002;1079–1085.
9. Hsu SI, Ramirez SB, Winn MP, Bomventre JV, Owen WF. Evidence for genetic factors in the development and progression of IgA nephropathy.
Kidney Int 57:2000;1818–1835.
10. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promotor: a possible role of polymorphism in expression regulation.
J Neuroimmunol 112:2001;146–152.
11. Choi HJ, Cho JH, Kim JC, Seo HJ, Hyun SH, Kim GH, Choi JY, Choi HJ, Ryu HM, Cho JH, Park SH, Kim YL, Han S, Kim CD. Interleukin–18, transforming growth factor–ß1, and vascular endothelial growth factor gene polymorphisms and susceptibility to primary glomerulonephritis.
Tissue Antigens 76:2010;289–296.
12. Sato F, Narita I, Goto S, Kondo D, Saito N, Ajiro J, Saga D, Ogawa A, Kadomura M, Akiyama F, Kaneko Y, Ueno M, Sakatsume M, Gejyo F. Transforming growth factor-beta1 gene polymorphism modifies the histological and clinical manifestations in Japanese patients with IgA nephropathy.
Tissue Antigens 64:2004;35–42.
13. Lim CS, Kim YS, Chae DW, Ahn C, Han JS, Kim S, Lee JS, Kim IS. Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with susceptibility to and progression of IgA nephropathy.
Clin Nephrol 63:2005;61–67.
14. Carturan S, Roccatello D, Menegatti E, Di Simone D, Davit A, Piazza A, Sena LM, Matullo G. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy.
J Nephrol 17:2004;786–793.
15. Vuong MT, Lundberg S, Gunnarsson I, Wramner L, Seddighzadeh M, Hahn-Zoric M, Fernström A, Hanson LA, Do LT, Jacobson SH, Padyukov L. Genetic variation in the transforming growth factor-beta1 gene is associated with susceptibility to IgA nephropathy.
Nephrol Dial Transplant 24:2009;3061–3067.
16. Chow KM, Szeto CC, Lai FM, Poon P, Wong TY, Li PK. Genetic polymorphism of vascular endothelial growth factor: impact on progression of IgA nephropathy.
Ren Fail 28:2006;15–20.
17. Kiliś-Pstrusińska K, Medyńska A, Zwolińska D, Wawro A. Interleukin-18 in urine and serum of children with idiopathic nephrotic syndrome.
Kidney Blood Press Res 31:2008;122–126.
18. Matsumoto K, Kanmatsuse K. Augmented interleukin-18 production by peripheral blood monocytes in patients with minimal-change nephrotic syndrome.
Am J Nephrol 21:2001;20–27.
19. Paydas S, Balal M, Tanriverdi K, Sertdemir Y, Baslamisli F. The relationship between the VEGF levels and VEGF mRNA expression and clinical course in different glomerulonephritis.
Ren Fail 29:2007;779–784.
20. van der Meer P, De Boer RA, White HL, van der Steege G, Hall AS, van Veldhuisen DJ. The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.
J Card Fail 11:2005;279–284.
21. Buzza M, Dagher H, Wang YY, Wilson D, Babon JJ, Cotton RG, Savige J. Mutations in COL4A4 gene in thin basement membrane disease.
Kidney Int 63:2003;447–453.